{"id":"lumason","rwe":[],"tags":[],"safety":{"boxedWarnings":["WARNING: SERIOUS CARDIOPULMONARY REACTIONS Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following the injection of ultrasound contrast agents, including sulfur hexafluoride lipid microspheres [see Warnings and Precautions ( 5.1 )] . Most serious reactions occur within 30 minutes of administration [see Warnings and Precautions ( 5.1 )] . Assess all patients for the presence of any condition that precludes administration [see Contraindications ( 4 )] "],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Headache","drugRate":"1%","severity":"mild to moderate","organSystem":""},{"effect":"Nausea","drugRate":"0.5%","severity":"mild to moderate","organSystem":""},{"effect":"Dysgeusia","drugRate":"0.4%","severity":"mild to moderate","organSystem":""},{"effect":"Injection site pain","drugRate":"0.3%","severity":"mild to moderate","organSystem":""},{"effect":"Feeling Hot","drugRate":"0.3%","severity":"mild to moderate","organSystem":""},{"effect":"Chest discomfort","drugRate":"0.2%","severity":"mild to moderate","organSystem":""},{"effect":"Chest pain","drugRate":"0.2%","severity":"mild to moderate","organSystem":""},{"effect":"Dizziness","drugRate":"0.2%","severity":"mild to moderate","organSystem":""},{"effect":"Injection Site Warmth","drugRate":"0.2%","severity":"mild to moderate","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Anaphylactic shock","drugRate":"","severity":"serious"},{"effect":"Hypersensitivity-type rash","drugRate":"","severity":"serious"},{"effect":"Presyncope","drugRate":"","severity":"serious"},{"effect":"Arrhythmias","drugRate":"","severity":"serious"},{"effect":"Hypertensive episodes","drugRate":"","severity":"serious"},{"effect":"Bronchospasm","drugRate":"","severity":"serious"},{"effect":"Dyspnea","drugRate":"","severity":"serious"},{"effect":"Angioedema","drugRate":"","severity":"serious"},{"effect":"Death","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1796998","moleculeType":"Small molecule","molecularWeight":"146.06"},"aliases":["SonoVue","Infusion Administration","sulfur hexafluoride","sulfur hexafluoride lipid-type A microspheres"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"69822a55-226c-f133-e3b8-2b5826667c5b","title":"LUMASON (SULFUR HEXAFLUORIDE) KIT LUMASON (SULFUR HEXAFLUORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [BRACCO DIAGNOSTICS INC]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-27T23:53:30.863Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[],"indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06400004","phase":"PHASE3","title":"Lumason® Infusion vs. Bolus Administrations","status":"RECRUITING","sponsor":"Bracco Diagnostics, Inc","startDate":"2024-07-10","conditions":"Heart Diseases","enrollment":106},{"nctId":"NCT06693752","phase":"PHASE2","title":"CEUS Evaluation of Hydrocephalus in Neonates and Infants","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2026-03-31","conditions":"Hydrocephalus in Infants, Hydrocephalus Acquired","enrollment":20},{"nctId":"NCT06261814","phase":"PHASE2","title":"Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors","status":"RECRUITING","sponsor":"john eisenbrey","startDate":"2024-08-07","conditions":"Liver Neoplasms","enrollment":266},{"nctId":"NCT05641935","phase":"PHASE2","title":"Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation","status":"RECRUITING","sponsor":"john eisenbrey","startDate":"2022-11-03","conditions":"Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma","enrollment":210},{"nctId":"NCT07385846","phase":"PHASE1","title":"Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Jennifer Leddon","startDate":"2026-06-01","conditions":"Glioblastoma, Mismatch Repair Deficiency","enrollment":8},{"nctId":"NCT06171607","phase":"PHASE1","title":"Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2020-11-05","conditions":"Breast Carcinoma","enrollment":100},{"nctId":"NCT03473249","phase":"PHASE4","title":"Effectiveness of Contrast-Enhanced Ultrasound","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-05-09","conditions":"Abdominal Injuries, Physical Abuse, Accidental Fall","enrollment":120},{"nctId":"NCT02911714","phase":"PHASE1","title":"Contrast-Enhanced Ultrasound for Kidney Transplant","status":"TERMINATED","sponsor":"University of Utah","startDate":"2018-02-21","conditions":"Kidney Transplantation","enrollment":20},{"nctId":"NCT03490929","phase":"PHASE4","title":"CEUS for Blunt Abdominal Trauma in Children","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-06-01","conditions":"Trauma Abdomen","enrollment":146},{"nctId":"NCT05957042","phase":"EARLY_PHASE1","title":"Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2023-09-01","conditions":"Breast Cancer, Contrast Enhanced Ultrasound","enrollment":""},{"nctId":"NCT07274787","phase":"NA","title":"Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"University of Cincinnati","startDate":"2026-01-01","conditions":"GBM","enrollment":10},{"nctId":"NCT05186415","phase":"PHASE1, PHASE2","title":"Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2022-08-23","conditions":"Tetralogy of Fallot, Pulmonary Insufficiency","enrollment":25},{"nctId":"NCT05569122","phase":"PHASE1","title":"Applying pGz in Mitochondrial Disease","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-03-22","conditions":"Mitochondrial Myopathies, Mitochondrial Diseases","enrollment":90},{"nctId":"NCT07145801","phase":"PHASE2","title":"Y-90 Treatment Response Using Transarterial Radioembolization","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-09-11","conditions":"HCC, Hepatocellular Carcinoma, Liver Cancer","enrollment":30},{"nctId":"NCT04718441","phase":"PHASE1, PHASE2","title":"Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)","status":"COMPLETED","sponsor":"David Mooney","startDate":"2021-05-10","conditions":"Abdominal Injury","enrollment":68},{"nctId":"NCT05206942","phase":"NA","title":"Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-03-21","conditions":"Solid Tumor","enrollment":30},{"nctId":"NCT07054229","phase":"","title":"Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-01-01","conditions":"Microwave Ablation, Contrast-enhanced Ultrasound, Genetic and Molecular Diagnostics","enrollment":480},{"nctId":"NCT03492944","phase":"","title":"Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-03-06","conditions":"Crohn Disease","enrollment":25},{"nctId":"NCT03549520","phase":"PHASE3","title":"CEUS Evaluation of Hypoxic Ischemic Injury","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-12-01","conditions":"Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia","enrollment":1},{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":"Alzheimer Disease, Early Onset","enrollment":6},{"nctId":"NCT03107520","phase":"EARLY_PHASE1","title":"Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2017-05-22","conditions":"Developmental Dysplasia of the Hip","enrollment":125},{"nctId":"NCT04720456","phase":"PHASE2","title":"SHAPE of Portal Hypertension in Children","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-11-03","conditions":"Hypertension, Portal","enrollment":120},{"nctId":"NCT06775977","phase":"","title":"Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-01-01","conditions":"Bladder Cancer, Staging, Contrast Enhanced Ultrasound","enrollment":480},{"nctId":"NCT03549507","phase":"PHASE3","title":"CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-11-04","conditions":"Necrotizing Enterocolitis of Newborn, Bowel Ischemic","enrollment":1},{"nctId":"NCT02950493","phase":"NA","title":"Use of Reactivated DEFINITY or LUMASON in Patients Undergoing Rest or Stress Echocardiography","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2017-04-06","conditions":"Stress Echocardiography","enrollment":20},{"nctId":"NCT03821376","phase":"PHASE4","title":"Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)","status":"TERMINATED","sponsor":"Indiana University","startDate":"2019-07-16","conditions":"Renal Malignant Tumor","enrollment":12},{"nctId":"NCT05025449","phase":"PHASE4","title":"BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-09-30","conditions":"Abdominal Trauma","enrollment":267},{"nctId":"NCT03652636","phase":"PHASE4","title":"Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions","status":"COMPLETED","sponsor":"Indiana University","startDate":"2019-08-05","conditions":"Hepatic Disease","enrollment":47},{"nctId":"NCT05613946","phase":"PHASE1","title":"Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-12-15","conditions":"Lymphedema Arm","enrollment":10},{"nctId":"NCT04640038","phase":"PHASE3","title":"Contrast Enhanced Ultrasound in COVID-19","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-12-18","conditions":"Covid19, Multisystem Inflammatory Syndrome in Children (MIS-C)","enrollment":4},{"nctId":"NCT03907657","phase":"PHASE2","title":"Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2019-09-23","conditions":"Von-Hippel Lindau, Kidney Disease, Chronic","enrollment":15},{"nctId":"NCT06329570","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)","status":"NOT_YET_RECRUITING","sponsor":"NaviFUS Corporation","startDate":"2024-07-01","conditions":"Glioblastoma Multiforme, Glioblastoma, Glioma","enrollment":10},{"nctId":"NCT04793633","phase":"","title":"Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"Adenocyte, LLC","startDate":"2024-01-31","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":500},{"nctId":"NCT05161013","phase":"NA","title":"A Proof-of-Concept Study Evaluating LINFU™","status":"COMPLETED","sponsor":"Adenocyte, LLC","startDate":"2021-10-21","conditions":"Pancreas Adenocarcinoma, Dysplasia","enrollment":12},{"nctId":"NCT04021238","phase":"PHASE2","title":"Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2020-10-07","conditions":"Kidney Cancer","enrollment":25},{"nctId":"NCT04569799","phase":"PHASE4","title":"Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2020-10-14","conditions":"Hepatocellular Carcinoma","enrollment":26},{"nctId":"NCT03687502","phase":"PHASE2","title":"The Role of Contrast Enhanced Ultrasound in Appendicitis","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2019-01-04","conditions":"Acute Appendicitis","enrollment":37},{"nctId":"NCT03653702","phase":"PHASE1","title":"Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)","status":"UNKNOWN","sponsor":"Boston Children's Hospital","startDate":"2023-10-01","conditions":"Vesico-Ureteral Reflux","enrollment":70},{"nctId":"NCT04150874","phase":"EARLY_PHASE1","title":"Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2020-02-19","conditions":"Hepatocellular Carcinoma, Liver Cancer","enrollment":4},{"nctId":"NCT03335033","phase":"PHASE2","title":"New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-11-15","conditions":"Carotid Artery Plaque","enrollment":54},{"nctId":"NCT03058614","phase":"PHASE2","title":"Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2017-06-30","conditions":"Ultrasonography, Nephrolithiasis","enrollment":""},{"nctId":"NCT03357081","phase":"","title":"Utility of Real-Time Contrast Enhanced Ultrasound (CEUS) in the Evaluation of Soft Tissue Hematomas","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-02-27","conditions":"Hematoma","enrollment":16},{"nctId":"NCT03954015","phase":"EARLY_PHASE1","title":"Comparison of Three Methods for Early Detection of Breast Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-10-15","conditions":"Proliferative Breast Disease","enrollment":3},{"nctId":"NCT03235180","phase":"PHASE4","title":"Ultrasound Evaluation of Crohn's Disease","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2017-06-16","conditions":"Crohn Disease","enrollment":9},{"nctId":"NCT02552238","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2015-10-12","conditions":"Coronary Artery Disease","enrollment":174},{"nctId":"NCT02522481","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2015-09-24","conditions":"Coronary Artery Disease","enrollment":175},{"nctId":"NCT03147690","phase":"PHASE1, PHASE2","title":"Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children","status":"TERMINATED","sponsor":"David Mooney","startDate":"2017-11-01","conditions":"Abdominal Injury","enrollment":74},{"nctId":"NCT03407001","phase":"EARLY_PHASE1","title":"Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-01-12","conditions":"Cirrhosis","enrollment":9},{"nctId":"NCT03295656","phase":"PHASE1","title":"Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2020-07-15","conditions":"Appendicitis Acute","enrollment":""},{"nctId":"NCT02282163","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography","status":"TERMINATED","sponsor":"Bracco Diagnostics, Inc","startDate":"2015-10","conditions":"Heart Disease","enrollment":13},{"nctId":"NCT03335020","phase":"PHASE1","title":"Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2018-04-01","conditions":"Fibromuscular Dysplasia of Arteries, Segmental Arterial Mediolysis, Spontaneous Coronary Artery Dissection","enrollment":""},{"nctId":"NCT03963999","phase":"PHASE4","title":"Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients","status":"WITHDRAWN","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2020-04-01","conditions":"Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Bone Marrow Transplant Complications","enrollment":""},{"nctId":"NCT03040323","phase":"PHASE4","title":"Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses","status":"TERMINATED","sponsor":"Indiana University","startDate":"2016-12-22","conditions":"Liver Biopsy","enrollment":83},{"nctId":"NCT02560467","phase":"NA","title":"Perfusion Imaging With Myocardial Contrast Echocardiography in HCM","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2015-12-01","conditions":"Hypertrophic Cardiomyopathy","enrollment":10},{"nctId":"NCT03300401","phase":"NA","title":"Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2017-11-07","conditions":"Hepatocellular Carcinoma","enrollment":""},{"nctId":"NCT03897153","phase":"NA","title":"Evaluation of the SONAS® Ultrasound Device for the Assessment of Bilateral Cerebral Perfusion in Subjects With Acute Stroke","status":"UNKNOWN","sponsor":"Burl Concepts, Inc.","startDate":"2019-02-12","conditions":"Stroke, Acute","enrollment":20},{"nctId":"NCT03296852","phase":"EARLY_PHASE1","title":"Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2018-04-19","conditions":"Stroke, Acute","enrollment":12},{"nctId":"NCT02786810","phase":"PHASE2","title":"Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2016-03","conditions":"Urinary Tract Infection, Vesicoureteral Reflux","enrollment":10},{"nctId":"NCT03061045","phase":"PHASE4","title":"Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2017-04-01","conditions":"Neonatal Post-Hemorrhagic Hydrocephalus","enrollment":""},{"nctId":"NCT01306292","phase":"PHASE2","title":"Safety of SonoVue on Pulmonary Hemodynamics","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2011-04","conditions":"Pulmonary Hypertension","enrollment":36}],"_emaApprovals":[],"_faersSignals":[{"count":231,"reaction":"DYSPNOEA"},{"count":190,"reaction":"NAUSEA"},{"count":182,"reaction":"ANAPHYLACTIC REACTION"},{"count":165,"reaction":"HYPERHIDROSIS"},{"count":132,"reaction":"FLUSHING"},{"count":114,"reaction":"DIZZINESS"},{"count":109,"reaction":"HYPERSENSITIVITY"},{"count":102,"reaction":"HYPOTENSION"},{"count":93,"reaction":"PARAESTHESIA"},{"count":92,"reaction":"BLOOD PRESSURE DECREASED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20141010","type":"ORIG","sponsor":"BRACCO","applicationNumber":"NDA203684"},{"date":"20210409","type":"SUPPL","sponsor":"BRACCO","applicationNumber":"NDA203684"},{"date":"20201202","type":"SUPPL","sponsor":"BRACCO","applicationNumber":"NDA203684"},{"date":"20191113","type":"SUPPL","sponsor":"BRACCO","applicationNumber":"NDA203684"},{"date":"20160331","type":"SUPPL","sponsor":"BRACCO","applicationNumber":"NDA203684"},{"date":"20161222","type":"SUPPL","sponsor":"BRACCO","applicationNumber":"NDA203684"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":64,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Lumason","genericName":"Lumason","companyName":"Mayo Clinic","companyId":"mayo-clinic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":13,"withResults":4},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}